SB-657510

Research use only, not for human use.

SB-657510 is a urotensin II (UII) receptor (UT) antagonist. The Ki values of UT for human, monkey, cat, rat and mouse were 61, 17, 30, 65 and 56 nM, respectively.

SB-657510 is a selective urotensin II (UII) receptor (UT) antagonist. The Ki values are 61, 17, 30, 65 and 56 nM for human, monkey, cat, rat and mouse receptors, respectively. SB-657510 exerts anti-inflammatory effects by inhibiting UII-induced upregulation of inflammatory mediators such as adhesion molecules, cytokines, and tissue factor in human vascular endothelial cells.

SB-657510 dramatically blocks the UII-induced increase in adhesion between U937 and EA.hy926 cell. SB-657510 (1 μM; 0.5-8 hours) blocks the expression of tissue factor induced by UII in endothelial cells.SB-706375 (1-10000 nM) inhibits [Ca2+]i mobilization elicited by 10?nM hU-II with an IC50 of 180?nM.Western Blot Analysis Cell Line:EA.hy926 cells (UII-induced)Concentration:1 μM Incubation Time:0.5, 1, 2, 4, 8 hours Result:Remarkably decreased the UII-induced protein expression of tissue factor.

SB-657510 inhibits the progression of high-fat diet induced atherosclerosis and diabetes-associated atherosclerosis.Levels of phosphorylated ERK are significantly attenuated in the aorta of SB-657510-treated (30 mg/kg/day) diabetic mice (Male Apoe KO mice).

——

GPCR/G Protein

Neurotensin Receptor

Neurotensin Receptor

——

——

474960-44-6

505.81

C19H22BrClN2O5S

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (197.70 mM; Ultrasonic )

COc1cc(Br)c(cc1OC)S(=O)(=O)Nc1ccc(Cl)c(O[C@@H]2CCN(C)C2)c1

——

(-20℃)

With Ice Pack

≥ 2 years